Novel tumor target for antibody-based therapy of rhabdomyosarcoma and other pediatric solid tumors
Shakeel Modak(Memorial Sloan Kettering Cancer Center), N K Cheung(Memorial Sloan Kettering Cancer Center), He Guo(GenomiCare (China)), John L. Humm(Memorial Sloan Kettering Cancer Center), Samantha Larson(University of Minnesota Health Maple Grove Clinics)
Cited by 0
Related Papers
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
|The Lancet|2010|1.1k
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|Journal of Clinical Oncology|1987|417
Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer
|European Journal of Nuclear Medicine and Molecular Imaging|2013|183